DEFA14A: Xenetic BioSciences Sets Annual Meeting for Dec 11

Xenetic BioSciences, Inc. announced its 2024 Annual Meeting of Stockholders will be held virtually on December 11, 2024, to vote on director elections, auditor ratification, and executive compensation.

Summary

• Xenetic BioSciences, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on December 11, 2024, at 10:00 AM EST.
• Stockholders are invited to vote on four key proposals, with the voting deadline set for December 10, 2024, at 11:59 PM ET.
• The proposals include the election of six directors: Grigory Borisenko, Firdaus Jal Dastoor, Dmitry Genkin, Roger Kornberg, Moshe Mizrahy, and Alexey Vinogradov.
• Stockholders will also vote to ratify Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• An advisory vote will be held to approve the company's named executive officer compensation.
• A non-binding advisory vote will determine the frequency of future votes on named executive officer compensation, with the Board recommending a '1 Year' frequency.
• Proxy materials, including the Proxy Statement, Form 10-K, and Form 10-K/A, are available online, and paper or email copies can be requested prior to November 27, 2024.

Sentiment

Score: 5

Explanation: The filing is a standard procedural announcement for an annual stockholder meeting, containing no new financial or operational information to influence sentiment.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Opportunity to exercise voting rights on key corporate governance matters, including director elections, auditor ratification, and executive compensation.

Next Steps

• Stockholders should review the Proxy Statement, Form 10-K, and Form 10-K/A online or request copies.
• Stockholders are encouraged to vote on the proposals by the December 10, 2024, deadline.
• Stockholders may attend the virtual Annual Meeting on December 11, 2024.

Key Dates

Recommendation

This filing is a routine announcement for the company's annual stockholder meeting, covering standard corporate governance proposals. It does not contain new financial results, strategic updates, or other material information that would alter an investment thesis, thus a 'hold' recommendation is appropriate for existing investors.

Keywords

Xenetic BioSciences, XBIO, Annual Meeting, Proxy Statement, Corporate Governance, Director Election, Auditor Ratification, Executive Compensation, Say on Pay